yeztugo

Generic: lenacapavir sodium

Labeler: gilead sciences, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name yeztugo
Generic Name lenacapavir sodium
Labeler gilead sciences, inc.
Dosage Form KIT
Manufacturer
Gilead Sciences, Inc.

Identifiers & Regulatory

Product NDC 61958-3402
Product ID 61958-3402_4fcd5eac-41a1-43cd-98c5-f733d5094ff9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA220018
Listing Expiration 2027-12-31
Marketing Start 2025-06-18

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 619583402
Hyphenated Format 61958-3402

Supplemental Identifiers

RxCUI
2625890 2625904 2625911 2717197 2717201 2717203
UNII
BDT58WJ9WE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name yeztugo (source: ndc)
Generic Name lenacapavir sodium (source: ndc)
Application Number NDA220018 (source: ndc)
Routes
oral
source: label

Resolved Composition

Strengths
  • 300 mg
  • 463.5 mg/1.5 ml
  • 309 mg/ml
  • 306.8 mg
  • 62 l
  • 473.1 mg/1.5 ml
source: label
Packaging
  • 1 KIT in 1 CARTON (61958-3402-1) * 1.5 mL in 1 VIAL (61958-3403-1)
source: ndc

Packages (1)

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"spl_id": "4fcd5eac-41a1-43cd-98c5-f733d5094ff9", "openfda": {"unii": ["BDT58WJ9WE"], "rxcui": ["2625890", "2625904", "2625911", "2717197", "2717201", "2717203"], "spl_set_id": ["1c241af1-ce62-4b0a-9eb7-f6b626174f01"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 CARTON (61958-3402-1)  *  1.5 mL in 1 VIAL (61958-3403-1)", "package_ndc": "61958-3402-1", "marketing_start_date": "20250618"}], "brand_name": "Yeztugo", "product_id": "61958-3402_4fcd5eac-41a1-43cd-98c5-f733d5094ff9", "dosage_form": "KIT", "product_ndc": "61958-3402", "generic_name": "LENACAPAVIR SODIUM", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Yeztugo", "application_number": "NDA220018", "marketing_category": "NDA", "marketing_start_date": "20250618", "listing_expiration_date": "20271231"}